The understanding of CCL18 function has been hampered until the recent identification of PITPNM3 (phosphatidylinositol transfer protein 3; also named PYK2 N-terminal domain interacting receptor 1, Nir1) in breast cancer, which has a high binding affinity for CCL18 [14]. Here, PITPNM3 is linked to breast carcinoma.